InvestorsHub Logo
icon url

TheExpertHimself

03/05/15 9:53 AM

#73257 RE: TheExpertHimself #73256

When we know the earnings of Capstone for 2014 and 2013, then we will know how good this deal is.

If Musclepharm based the rationale of the deal entirely on expected earnings of Capstone in 2015, that would be very alarming.